Overview

Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Treatments:
Alemtuzumab